Product Information
DEXMETHYLPHENIDATE ER 5 MG CAP is a generic product labeled by Granules Pharmaceuticals Inc., priced at $1.0137 per EA under NDC 70010000401. Its NADAC has been published 295 times since Feb 10, 2021.
FDA first approved this application on Sep 9, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Granules Pharmaceuticals Inc.NDC
70010000401
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXMETHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213813FDA Approved
9/9/2020
TE Code
AB
On Market Since
12/1/2020
Pharmacological Classes
Price Statistics
The NADAC for DEXMETHYLPHENIDATE ER 5 MG CAP has been published 295 times since Feb 10, 2021, and over the history we have for it it has declined 53.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0137 per EA |
|---|---|
| All-time high | $2.1698 (Feb 10, 2021) |
| All-time low | $0.6402 (Jan 17, 2024) |
| 52-week high | $1.2215 |
| 52-week low | $0.9644 |
| Median price | $1.1435 |
| Average price | $1.1563 |
| Largest weekly change | +58.1% (Mar 20, 2024) |
| Weeks tracked | 295 |
| Tracking since | Feb 10, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the DEXMETHYLPHENIDATE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Granules Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
DEXMETHYLPHENIDATE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DEXMETHYLPHENIDATE ER 5 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DEXMETHYLPHENIDATE ER 5 MG CAP, manufactured by Granules Pharmaceuticals Inc., is $1.0137 per EA (NDC 70010000401), effective Sep 30, 2026.
How has the price of DEXMETHYLPHENIDATE ER 5 MG CAP changed over time?
Over the history we have for it, the NADAC for DEXMETHYLPHENIDATE ER 5 MG CAP has declined 53.3%. It has been tracked across 295 weekly CMS publications since Feb 10, 2021.
What are the highest and lowest recorded NADAC prices for DEXMETHYLPHENIDATE ER 5 MG CAP?
Since Feb 10, 2021, the NADAC for DEXMETHYLPHENIDATE ER 5 MG CAP has ranged from a low of $0.6402 (Jan 17, 2024) to a high of $2.1698 (Feb 10, 2021), with a median of $1.1435 per EA.
Are there cheaper alternatives to DEXMETHYLPHENIDATE ER 5 MG CAP?
No other NADAC-published product currently shares the active ingredient and strength of DEXMETHYLPHENIDATE ER 5 MG CAP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DEXMETHYLPHENIDATE ER 5 MG CAP?
DEXMETHYLPHENIDATE ER 5 MG CAP (NDC 70010000401) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.